The clinical significance of infections with cytomegalovirus strains resistant to antiviral drugs (Q43571846)

24 November 2017

title

The clinical significance of infections with cytomegalovirus strains resistant to antiviral drugs (English)

1 reference

24 November 2017

Balfour HH Jr

1

1 reference

24 November 2017

publication date

1 May 1992

1 reference

24 November 2017

1 reference

24 November 2017

volume

143

1 reference

24 November 2017

issue

3

1 reference

24 November 2017

page(s)

219-221

1 reference

Management of cytomegalovirus disease with antiviral drugs

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980108-1

7 January 2021

A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal Allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980108-1

7 January 2021

Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980108-1

7 January 2021

Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980108-1

7 January 2021

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980108-1

7 January 2021

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980108-1

7 January 2021

Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980108-1

7 January 2021

Cytomegalovirus retinitis and acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980108-1

7 January 2021

Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980108-1

7 January 2021

Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980108-1

7 January 2021

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980108-1

7 January 2021

A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980108-1

7 January 2021

Cytomegalovirus: Clinical virological correlations in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980108-1

7 January 2021

Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980108-1

7 January 2021

10.1016/S0923-2516(06)80108-1

Identifiers

DOI

1 reference

24 November 2017

1 reference